DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name ▲ | UniProt ID |
---|---|---|---|---|---|
C0042109 | Urticaria | ELOVL4 | 6785 | ELOVL fatty acid elongase 4 | Q9GZR5 |
C0020758 | Congenital ichthyosis | ELOVL4 | 6785 | ELOVL fatty acid elongase 4 | Q9GZR5 |
C0007758 | Cerebellar Ataxia | ELOVL4 | 6785 | ELOVL fatty acid elongase 4 | Q9GZR5 |
C0037268 | Skin Abnormalities | ELOVL4 | 6785 | ELOVL fatty acid elongase 4 | Q9GZR5 |
C0087012 | Ataxia, Spinocerebellar | ELOVL4 | 6785 | ELOVL fatty acid elongase 4 | Q9GZR5 |
C0023903 | Liver neoplasms | ELOVL4 | 6785 | ELOVL fatty acid elongase 4 | Q9GZR5 |
C1864446 | Retinitis Pigmentosa 25 | ELOVL4 | 6785 | ELOVL fatty acid elongase 4 | Q9GZR5 |
C0011847 | Diabetes | ELOVL4 | 6785 | ELOVL fatty acid elongase 4 | Q9GZR5 |
C0027651 | Neoplasms | ELOVL4 | 6785 | ELOVL fatty acid elongase 4 | Q9GZR5 |
C0339527 | Leber Congenital Amaurosis | ELOVL4 | 6785 | ELOVL fatty acid elongase 4 | Q9GZR5 |
C0079583 | Ichthyosiform Erythroderma, Congenital | ELOVL4 | 6785 | ELOVL fatty acid elongase 4 | Q9GZR5 |
C4518337 | Spinocerebellar ataxia type 38 | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C0007102 | Malignant tumor of colon | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C0036341 | Schizophrenia | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C0007758 | Cerebellar Ataxia | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C0011849 | Diabetes Mellitus | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C2675481 | COLORECTAL CANCER, SUSCEPTIBILITY TO, 10 | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C0376358 | Malignant neoplasm of prostate | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C0087012 | Ataxia, Spinocerebellar | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C1837315 | COLORECTAL CANCER, SUSCEPTIBILITY TO, 1 | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C0017601 | Glaucoma | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C0022658 | Kidney Diseases | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C0152136 | Low Tension Glaucoma | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C0027051 | Myocardial Infarction | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
C0009402 | Colorectal Carcinoma | ELOVL5 | 60481 | ELOVL fatty acid elongase 5 | Q9NYP7 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024